Viral induced demyelination
- PMID: 11145206
- PMCID: PMC7161848
- DOI: 10.1111/j.1750-3639.2001.tb00384.x
Viral induced demyelination
Abstract
Viral induced demyelination, in both humans and rodent models, has provided unique insights into the cell biology of oligodendroglia, their complex cell-cell interactions and mechanisms of myelin destruction. They illustrate mechanisms of viral persistence, including latent infections in which no infectious virus is readily evident, virus reactivation and viral-induced tissue damage. These studies have also provided excellent paradigms to study the interactions between the immune system and the central nervous system (CNS). Although of interest in their own right, an understanding of the diverse mechanisms used by viruses to induce demyelination may shed light into the etiology and pathogenesis of the common demyelinating disorder multiple sclerosis (MS). This notion is supported by the persistent view that a viral infection acquired during adolescence might initiate MS after a long period of quiescence. Demyelination in both humans and rodents can be initiated by infection with a diverse group of enveloped and non-enveloped RNA and DNA viruses (Table 1). The mechanisms that ultimately result in the loss of CNS myelin appear to be equally diverse as the etiological agents capable of causing diseases which result in demyelination. Although demyelination can be a secondary result of axonal loss, in many examples of viral induced demyelination, myelin loss is primary and associated with axonal sparing. This suggests that demyelination induced by viral infections can result from: 1) a direct viral infection of oligodendroglia resulting in cell death with degeneration of myelin and its subsequent removal; 2) a persistent viral infection, in the presence or absence of infectious virus, resulting in the loss of normal cellular homeostasis and subsequent oligodendroglial death; 3) a vigorous virus-specific inflammatory response wherein the virus replicates in a cell type other than oligodendroglia, but cytokines and other immune mediators directly damage the oligodendroglia or the myelin sheath; or 4) infection initiates activation of an immune response specific for either oligodendroglia or myelin components. Virus-induced inflammation may be associated with the processing of myelin or oligodendroglial components and their presentation to the host's own T cell compartment. Alternatively, antigenic epitopes derived from the viral proteins may exhibit sufficient homology to host components that the immune response to the virus activates autoreactive T cells, i.e. molecular mimicry. Although it is not clear that each of these potential mechanisms participates in the pathogenesis of human demyelinating disease, analysis of the diverse demyelinating viral infections of both humans and rodents provides examples of many of these potential mechanisms.
Similar articles
-
Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination.Am J Pathol. 2006 Mar;168(3):796-804. doi: 10.2353/ajpath.2006.050496. Am J Pathol. 2006. PMID: 16507895 Free PMC article.
-
Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis.J Virol. 2019 Aug 28;93(18):e00240-19. doi: 10.1128/JVI.00240-19. Print 2019 Sep 15. J Virol. 2019. PMID: 31243125 Free PMC article.
-
Virus demyelination.J Neurovirol. 2003 Apr;9(2):148-64. doi: 10.1080/13550280390194046. J Neurovirol. 2003. PMID: 12707846 Free PMC article. Review.
-
Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination.J Neuroimmunol. 2001 Aug 30;118(2):256-67. doi: 10.1016/s0165-5728(01)00338-1. J Neuroimmunol. 2001. PMID: 11498260
-
Inside-Out versus Outside-In models for virus induced demyelination: axonal damage triggering demyelination.Springer Semin Immunopathol. 2002;24(2):105-25. doi: 10.1007/s00281-002-0105-z. Springer Semin Immunopathol. 2002. PMID: 12503060 Free PMC article. Review.
Cited by
-
In silico modelling of neuron signal impact of cytokine storm-induced demyelination.Open Biol. 2024 Sep;14(9):240138. doi: 10.1098/rsob.240138. Epub 2024 Sep 4. Open Biol. 2024. PMID: 39226928 Free PMC article.
-
Visual evoked potential abnormalities in patients with COVID-19.Rev Assoc Med Bras (1992). 2024 Mar 4;70(2):e20231061. doi: 10.1590/1806-9282.20231061. eCollection 2024. Rev Assoc Med Bras (1992). 2024. PMID: 38451579 Free PMC article.
-
The immune system in neurological diseases: What innate-like T cells have to say.J Allergy Clin Immunol. 2024 Apr;153(4):913-923. doi: 10.1016/j.jaci.2024.02.003. Epub 2024 Feb 15. J Allergy Clin Immunol. 2024. PMID: 38365015 Review.
-
The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System.Viruses. 2024 Jan 13;16(1):119. doi: 10.3390/v16010119. Viruses. 2024. PMID: 38257819 Free PMC article. Review.
-
The Impact of Innate Components on Viral Pathogenesis in the Neurotropic Coronavirus Encephalomyelitis Mouse Model.Viruses. 2023 Dec 9;15(12):2400. doi: 10.3390/v15122400. Viruses. 2023. PMID: 38140641 Free PMC article. Review.
References
-
- Barbano RL, Dal Canto MC (1984). Serum and cells from Theiler's virus‐infected mice fail to injure myelinating cultures or to produce in vivo transfer of diseases. The pathogenesis of Theiler's virus‐induced demyelination appears to differ from that of EAE. J Neurol Sci 66:283–293. - PubMed
-
- Begolka WS, Vanderlugt CL, Rahbe SM, Miller SD (1998) Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J Immunol 161:4437–4446. - PubMed
-
- Barac‐Latas V, Suchanek G, Breitschopf H, Stuehler A, Wege H, Lassmann H (1997) Patterns of oligodendrocyte pathology in coronavirus‐induced subacute demyelinating encephalomyelitis in the Lewis rat. Glia 19:1–12. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical